Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cimpress
CMPR
$2.29B
| $116M | 0.08% |
2,655,935
+7,589
| +0.3% | +$259K |
|
|
TWNK
227
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $115M | 0.08% |
4,630,406
-267,971
| -5% | -$6.31M |
|
228
Capital One
COF
$134B
| $114M | 0.08% |
1,188,494
+3,550
| +0.3% | +$372K |
|
|
MRSH
229
Marsh
MRSH
$90.6B
| $114M | 0.08% |
685,377
-1,080
| -0.2% | -$180K |
|
230
ITT
ITT
$18.9B
| $114M | 0.08% |
1,321,807
+19,595
| +2% | +$1.72M |
|
|
ISEE
231
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $114M | 0.08% |
4,687,209
+133,305
| +3% | +$2.92M |
|
232
EnerSys
ENS
$6.85B
| $114M | 0.08% |
1,310,200
-146,461
| -10% | -$12.3M |
|
233
MSCI
MSCI
$40.8B
| $111M | 0.07% |
198,762
-43,462
| -18% | -$23M |
|
234
Telus
TU
$15.2B
| $111M | 0.07% |
5,595,817
-55,013
| -1% | -$1.12M |
|
|
WNS
235
DELISTED
WNS Holdings
WNS
| $110M | 0.07% |
1,178,198
-3,148
| -0.3% | -$274K |
|
236
Applied Materials
AMAT
$421B
| $110M | 0.07% |
892,974
+36,342
| +4% | +$4.17M |
|
|
HI
237
DELISTED
Hillenbrand
HI
| $107M | 0.07% |
2,243,655
+870,549
| +63% | +$40M |
|
238
Ardelyx
ARDX
$972M
| $106M | 0.07% |
22,111,601
+2,337,268
| +12% | +$7.88M |
|
239
Saia
SAIA
$9.5B
| $106M | 0.07% |
388,301
-6,574
| -2% | -$1.75M |
|
240
Snowflake
SNOW
$116B
| $105M | 0.07% |
678,127
-49,094
| -7% | -$7.2M |
|
|
ALTR
241
DELISTED
Altair Engineering Inc
ALTR
| $104M | 0.07% |
1,446,355
-145,829
| -9% | -$8.62M |
|
242
Maximus
MMS
$2.92B
| $104M | 0.07% |
1,318,190
-183,155
| -12% | -$14.1M |
|
243
Carlisle Companies
CSL
$15.3B
| $103M | 0.07% |
455,694
-18,370
| -4% | -$4.47M |
|
244
Penumbra
PEN
$12.8B
| $103M | 0.07% |
368,389
-54,299
| -13% | -$13.9M |
|
245
TriNet
TNET
$3.1B
| $103M | 0.07% |
1,272,474
-86,854
| -6% | -$6.8M |
|
246
Marriott International
MAR
$90.9B
| $102M | 0.07% |
611,975
+241,470
| +65% | +$40.2M |
|
247
Rivian
RIVN
$23.3B
| $101M | 0.07% |
6,531,674
+33,226
| +0.5% | +$561K |
|
248
Vistra
VST
$48.6B
| $100M | 0.07% |
4,174,621
-14,457
| -0.3% | -$335K |
|
249
Jazz Pharmaceuticals
JAZZ
$16.6B
| $99.9M | 0.07% |
682,973
-413,870
| -38% | -$61.2M |
|
250
Intuitive Surgical
ISRG
$138B
| $99.8M | 0.07% |
390,848
-453,218
| -54% | -$112M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.